SCR-LIP-000581 · Claim · JSON legível por máquina →
O tecido adiposo do lipedema é relatado como apresentando características histológicas e moleculares diferentes das do tecido controle de massa corporal semelhante e do linfedema.
Proposição geral consolidada a partir de 5 claims anteriores de artigo único; o resultado de cada estudo aparece como achado.
Claim em resumo
- Tipo
- associação clínica
- Estado do conhecimento
- Emergente
- Certeza da evidência
- moderada (GRADE)
- Evidência
- 6 fonte(s)
- Responde a
- 1 pergunta(s)
- Datas
- 2026-11-20 → 2026-11-20
Evidência estruturada, compilada por máquina — não é um veredito.
Evidência ao longo do tempo
Evidência (6)
- Adipose Tissue Hypertrophy, An Aberrant Biochemical Profile and Distinct Gene Expression in Lipedema — Felmerer et al. (2020) ✓ verificado — consistente · cross sectional · 2020 · confiança da leitura: high
Versus BMI-matched controls, lipedema tissue showed adipocyte hypertrophy, intercellular fibrosis, epidermal thickening, aberrant lipid metabolism and a distinct adipogenesis gene expression profile (small sample).
The study directly compares lipedema patients to BMI-matched controls using histopathology, serum analysis, and gene expression arrays, finding distinct molecular and morphological hallmarks; however, the sample size is small (10 lipedema, - A Comparative Analysis to Dissect the Histological and Molecular Differences among Lipedema, Lipohypertrophy and Secondary Lymphedema — von Atzigen et al. (2023) ✓ verificado — consistente · cross sectional · 2023 · confiança da leitura: high
“VEGF-R3 aumentado exclusivamente em linfedema (3,227±1,067 fold) vs todas as condições (lipedema 1,006, lipohipertrofia 1,406) — marcador molecular específico de linfedema”
Comparing lipedema, lipohypertrophy and secondary lymphedema, VEGF-R3 was increased only in lymphedema (3.2-fold vs 1.0 in lipedema), indicating distinct histological and molecular profiles.
The study directly compares lipedema, lipohypertrophy, and secondary lymphedema using histological and molecular methods in matched samples, identifying distinct characteristics that support lipedema as a separate condition from both obesit - Increased levels of VEGF-C and macrophage infiltration in lipedema patients without changes in lymphatic vascular morphology — Felmerer et al. (2020) ✓ verificado — consistente · cross sectional · 2020 · confiança da leitura: moderate
“Lipedema is a chronic adipose tissue disorder characterized by the disproportional subcutaneous deposition of fat and is commonly misdiagnosed as lymphedema or obesity.”
Biopsies from 11 lipedema vs 10 BMI-matched healthy controls: CD45+ leukocytes 40.7 vs 20 per field, CD68+ macrophages increased with M2 polarisation, serum VEGF-C elevated, no lymphatic morphology changes.
The article directly characterizes inflammatory mechanisms in lipedema tissue, demonstrating macrophage infiltration with M2 polarization and a VEGF-C/lymphatic-axis profile, which bears on the inflammation mechanism component of the questi - Vascular remodeling of adipose tissue in lipedema: endothelial dysfunction as an emerging culprit in a mysterious disease — Allerton (2025) ✓ verificado — consistente · review · 2025 · confiança da leitura: moderate
“Estudo demonstra que a patologia vascular e adipocitária do lipedema é INDEPENDENTE da obesidade (pacientes com BMI < 24,9 afetadas)”
Commentary on histopathology in normal-BMI early-stage lipedema: macrophage infiltration only in affected areas, endothelial and pericyte hyperproliferation and barrier degeneration, indicating pathology independent of obesity.
This is a commentary/review contextualizing histopathological findings (Michelini et al.) that describe inflammatory (CD68+ macrophages) and vascular/endothelial dysfunction mechanisms in lipedema tissue, directly bearing on the question ab - Current Mechanistic Understandings of Lymphedema and Lipedema: Tales of Fluid, Fat, and Fibrosis — Duhon et al. (2022) ✓ verificado — consistente · review · 2022 · confiança da leitura: high
“AUSÊNCIA da assinatura T cell do linfedema. ECM fibrótica identificada em 2 coortes independentes (Felmerer 2020; Suga 2009). VEGF-C elevado SEM alterações na arquitetura linfática (Felmerer 2020) — contraste direto com linfedema”
Review: lipedema lacks the T-cell signature of lymphedema, shows fibrotic extracellular matrix and elevated VEGF-C without altered lymphatic architecture; the two diverge in time course, regulators and genetics.
This narrative review directly addresses the distinction between lipedema and lymphedema by comparing their pathophysiology, molecular regulators, and genetics, supporting the notion that lipedema is a distinct condition; however, as a revi - Lipedema: Insights into Morphology, Pathophysiology, and Challenges — Poojari et al. (2022) ✓ verificado — consistente · review · 2022 · confiança da leitura: high
“Biomarcadores em investigação: exossomas, lipidômica, metabolômica, perfil de citocinas — sugerem condição distinta de obesidade e linfedema”
Review: exosome, cytokine, lipidomic and metabolomic profiling suggest lipedema is distinct from obesity and lymphedema, with fat cell hyperproliferation, fibrosis and inflammation.
This is a narrative review that explicitly states promising biomarkers distinguish lipedema from obesity and lymphedema, and describes unique morphological and pathophysiological features; however, as a review it synthesizes existing limite
Contexto (PECO)
Responde a estas perguntas
Lacunas e ressalvas
Histórico de mudanças
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000001